RevBio Enters the Animal Health Market to Help Improve Canine Dental Care
RevBio Initiates a Clinical Study to Help Prevent Mandibular Fractures in Dogs Using its Bone Adhesive Biomaterial
News provided by
Share this article
Share this article
LOWELL, Mass., Feb. 4, 2021 /PRNewswire/ -- As its first veterinary application, RevBio, Inc. announced that it has initiated a clinical study to validate the use of its innovative bone adhesive biomaterial to fill tooth extraction sockets in dogs in order to improve healing, maintain and support jaw thickness, and restore the structural stability which may help resist potential mandibular fractures.
Working with several Diplomates of the American Veterinary Dental College, RevBio is conducting a clinical trial for its innovative bone adhesive biomaterial to fill tooth extraction sockets and improve healing in dogs.